Menu
GeneBe

rs145522874

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001145809.2(MYH14):c.4705G>T(p.Ala1569Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000761 in 1,589,196 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00037 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000045 ( 0 hom. )

Consequence

MYH14
NM_001145809.2 missense

Scores

6
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 2.58
Variant links:
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.030436993).
BP6
Variant 19-50286647-G-T is Benign according to our data. Variant chr19-50286647-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 164199.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000374 (57/152374) while in subpopulation AMR AF= 0.00111 (17/15304). AF 95% confidence interval is 0.000707. There are 0 homozygotes in gnomad4. There are 25 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High AC in GnomAd at 57 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYH14NM_001145809.2 linkuse as main transcriptc.4705G>T p.Ala1569Ser missense_variant 34/43 ENST00000642316.2
MYH14NM_001077186.2 linkuse as main transcriptc.4606G>T p.Ala1536Ser missense_variant 33/42
MYH14NM_024729.4 linkuse as main transcriptc.4582G>T p.Ala1528Ser missense_variant 32/41

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYH14ENST00000642316.2 linkuse as main transcriptc.4705G>T p.Ala1569Ser missense_variant 34/43 NM_001145809.2 Q7Z406-2

Frequencies

GnomAD3 genomes
AF:
0.000374
AC:
57
AN:
152256
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000892
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.0000934
AC:
19
AN:
203334
Hom.:
0
AF XY:
0.0000182
AC XY:
2
AN XY:
109888
show subpopulations
Gnomad AFR exome
AF:
0.00103
Gnomad AMR exome
AF:
0.000208
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000191
GnomAD4 exome
AF:
0.0000445
AC:
64
AN:
1436822
Hom.:
0
Cov.:
31
AF XY:
0.0000309
AC XY:
22
AN XY:
712250
show subpopulations
Gnomad4 AFR exome
AF:
0.00127
Gnomad4 AMR exome
AF:
0.000325
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.000151
GnomAD4 genome
AF:
0.000374
AC:
57
AN:
152374
Hom.:
0
Cov.:
33
AF XY:
0.000336
AC XY:
25
AN XY:
74514
show subpopulations
Gnomad4 AFR
AF:
0.000890
Gnomad4 AMR
AF:
0.00111
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.000253
Hom.:
0
Bravo
AF:
0.000646
ESP6500AA
AF:
0.000714
AC:
3
ESP6500EA
AF:
0.000119
AC:
1
ExAC
AF:
0.0000913
AC:
11
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingGeneDxAug 04, 2021- -
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 30, 2024- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMay 11, 2014Variant classified as Uncertain Significance - Favor Benign. The Ala1569Ser vari ant in MYH14 has not been previously reported in individuals with hearing loss, but has been identified in 0.07% (3/4202) of African American chromosomes and 0. 01% (1/8436) European American chromosomes by the NHLBI Exome Sequencing Project , and in 1.0% (2/190) of Luhya (Kenyan) chromosomes and 0.8% (1/119) of Columbia n chromosomes by the 1000 Genomes Project (http://evs.gs.washington.edu/EVS/; db SNP rs145522874). Computational prediction tools and conservation analyses do no t provide strong support for or against an impact to the protein. In summary, wh ile the clinical significance of the Ala1569Ser variant is uncertain, its presen ce in several racially diverse populations at a range of frequencies (0.01% - 1. 0%) suggests a more likely benign role. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 03, 2024The c.4582G>T (p.A1528S) alteration is located in exon 32 (coding exon 31) of the MYH14 gene. This alteration results from a G to T substitution at nucleotide position 4582, causing the alanine (A) at amino acid position 1528 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.34
Cadd
Uncertain
24
Dann
Uncertain
1.0
Eigen
Uncertain
0.31
Eigen_PC
Uncertain
0.34
FATHMM_MKL
Uncertain
0.93
D
M_CAP
Benign
0.035
D
MetaRNN
Benign
0.030
T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.0013
T
MutationTaster
Benign
0.75
D;D;D;D
PrimateAI
Uncertain
0.68
T
Sift4G
Benign
0.71
T;T;T;T;.;T;T
Polyphen
0.88
P;.;P;P;P;P;P
Vest4
0.38
MVP
0.68
MPC
0.44
ClinPred
0.049
T
GERP RS
4.5
Varity_R
0.081
gMVP
0.095

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145522874; hg19: chr19-50789904; API